Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: Ophthalmic Epidemiol. 2021 Feb 21;28(6):533–539. doi: 10.1080/09286586.2021.1883675

Table 4.

Payments per covered year for SD vs. SHL

Variables Coefficient (95% CI) P-value
Condition
 SD Reference
 SHL − 47.83 (− 49.98, − 45.67) <0.001
Age − 0.33 (− 0.34, − 0.31) <0.001
Sex
 Male Reference
 Female − 3.57 (− 4.07, − 3.07) <0.001
Year service was rendered
 2010 Reference
 2011 − 16.40 (− 17.17, − 15.63) <0.001
 2012 − 20.67 − 21.44, − 19.89) <0.001
 2013 − 18.21 (− 18.99, − 17.42) <0.001
 2014 − 12.76 (− 13.55, − 11.97) <0.001
Type of benefit plan
 PPO Reference
 Comprehensive − 1.73 (− 3.30, − 0.17) 0.030
 EPO 6.81 (5.27, 8.35) <0.001
 HMO − 4.23 (− 4.99, − 3.47) <0.001
 POS − 1.93 (− 2.88, − 0.99) <0.001
 POS with capitation − 1.13 (− 4.30, 2.03) 0.483
 CDHP − 2.54 (− 3.69, − 1.39) <0.001
 HDHP 0.28 (− 1.05, 1.61) 0.676

CI: confidence interval, SD: stargardt disease, SHL: bilateral sensorineural hearing loss, PPO: preferred provider organization, EPO: exclusive provider organization, HMO: health maintenance organization, POS: point-of-service, CDHP: consumer directed health plan, HDHP: high deductible health plan